U.S. Software Stock News

NYSE:BNED
NYSE:BNEDSpecialty Retail

Barnes & Noble Education (BNED) Q4 Loss Narrows, Testing Bearish Profitability Narratives

Barnes & Noble Education (BNED) has just wrapped up FY 2025 with fourth quarter revenue of $278.3 million and a basic EPS of about -$0.67, alongside trailing 12 month revenue of roughly $1.6 billion and EPS of about -$2.50. These figures underscore an earnings profile still under pressure. The company has seen quarterly revenue move from $235.9 million in Q4 FY 2024 through $602.1 million in Q2 FY 2025 before landing at $278.3 million in Q4 FY 2025. EPS has swung from about -$14.95 to as high...
NasdaqGS:MOMO
NasdaqGS:MOMOInteractive Media and Services

Hello Group (MOMO) Valuation Review After Weaker 2025 Results and Cautious Q4 Revenue Guidance

Hello Group (MOMO) just posted softer third quarter numbers, with both revenue and net income slipping versus last year, and followed up with fourth quarter guidance that points to another year over year revenue decline. See our latest analysis for Hello Group. The muted third quarter and cautious guidance help explain why Hello Group’s share price return is down over the past month and year to date, while the one year total shareholder return is also negative, signalling momentum is still...
NasdaqGS:CARG
NasdaqGS:CARGInteractive Media and Services

High Growth Tech Stocks To Watch In US December 2025

As the United States market experiences a fourth consecutive session of gains, buoyed by better-than-expected GDP growth and a tech sector rally, attention turns to high-growth tech stocks that are poised to navigate these dynamic conditions. In this environment, identifying promising stocks involves assessing their potential for innovation and adaptability in response to economic shifts and technological advancements.
NasdaqGS:UXIN
NasdaqGS:UXINSpecialty Retail

3 Growth Companies With Insider Ownership Up To 37%

As the U.S. market experiences a fourth consecutive session of gains, buoyed by better-than-expected GDP data and a strong tech sector performance, investors are increasingly focusing on growth companies with significant insider ownership. In this context, stocks with high levels of insider investment can be particularly appealing as they often indicate confidence in the company's future prospects amidst an evolving economic landscape.
NasdaqCM:ZJK
NasdaqCM:ZJKMachinery

Top Penny Stocks To Watch In December 2025

As the U.S. market continues to rally, with major stock indexes gaining for a fourth consecutive session and GDP data surpassing expectations, investors are keeping a close eye on potential opportunities. Despite their vintage-sounding name, penny stocks remain an intriguing sector of the market due to their potential for significant returns when backed by strong financials. This article will explore three penny stocks that stand out for their financial strength and growth potential, offering...
NasdaqGS:AMSC
NasdaqGS:AMSCElectrical

US Market's Undiscovered Gems December 2025

Amid a backdrop of rising stock indices and stronger-than-expected GDP growth, the U.S. market continues to capture investor attention with its robust economic performance. As major indices like the Dow Jones and S&P 500 gain ground, discerning investors are increasingly turning their focus toward uncovering small-cap stocks that may offer unique opportunities in this dynamic environment.
NasdaqGM:IVVD
NasdaqGM:IVVDBiotechs

Is Invivyd’s (IVVD) Index Debut Quietly Reframing Its Long-Term Biotech Positioning?

In December 2025, Invivyd, Inc. was added to both the NASDAQ Biotechnology Index and the S&P Biotechnology Select Industry Index, marking a step-up in its visibility within the biotech sector. These index inclusions can broaden Invivyd’s shareholder base by drawing interest from index-tracking funds and institutional investors that benchmark against these biotech indices. We’ll now explore how Invivyd’s addition to major biotechnology indices could influence its investment narrative and...
NasdaqGM:BCAX
NasdaqGM:BCAXBiotechs

How Bicara's Dual Biotech Index Additions Will Impact Bicara Therapeutics (BCAX) Investors

Earlier in December 2025, Bicara Therapeutics Inc. was added to both the NASDAQ Biotechnology Index and the S&P Biotechnology Select Industry Index, marking its inclusion in two widely followed biotech benchmarks. This dual index inclusion can enhance Bicara’s visibility among institutional investors and index-tracking funds, potentially broadening its shareholder base and liquidity profile. We’ll now examine how Bicara’s entry into major biotechnology indices shapes its investment...
NasdaqGS:DSGR
NasdaqGS:DSGRTrade Distributors

Assessing Distribution Solutions Group’s (DSGR) Valuation After Its Expanded Credit Facility Through 2030

Distribution Solutions Group (DSGR) just secured a larger, extended credit facility running through 2030, increasing both its term debt and revolving credit, and effectively giving management more flexibility to fund future growth initiatives. See our latest analysis for Distribution Solutions Group. Even with the expanded credit facility hinting at bolder growth plans, the stock has been under pressure, with a weak year to date share price return but still a solid three year total...
NYSE:TUYA
NYSE:TUYASoftware

Discovering Connect Biopharma Holdings And 2 Other Promising Penny Stocks

As the U.S. stock market continues to rally, with major indexes like the S&P 500 and Dow Jones nearing record highs, investors are increasingly looking for opportunities in less traditional areas. Penny stocks, though often considered a relic of past market trends, remain a compelling option for those seeking growth potential at lower price points. These stocks typically represent smaller or newer companies and can offer significant upside when backed by strong financial health and solid...